scispace - formally typeset
Search or ask a question
Topic

Dengue fever

About: Dengue fever is a research topic. Over the lifetime, 17463 publications have been published within this topic receiving 485745 citations. The topic is also known as: Dengue & dengue disease.


Papers
More filters
Journal ArticleDOI
15 Sep 2002-Virology
TL;DR: The ratio of nonsynonymous-to-synonymous nucleotide changes within a DEN-3 virus population from a single patient was less than the ratio among the consensus sequences ofDEN-3 viruses from different patients, suggesting that many of the nonsynonym nucleotideChanges which occurred naturally in the E protein were deleterious and removed by purifying selection.

175 citations

Journal ArticleDOI
TL;DR: Three improvements are necessary to standardise the dengue haemorrhagic fever definition and to allow it to do well in different populations: redefine the threshold for thrombocytopenia, clarify the standard practice and value of the tourniquet test, and incorporate a criterion to measure intravenous fluid replacement.
Abstract: Dengue fever imposes a societal burden that is difficult to measure because of the disease's non-specific symptoms and the lack of easily applied case definitions for its more severe manifestations. An efficacy trial of a tetravalent vaccine is expected in the near future, but only one of the severe dengue syndromes-the continuum of dengue haemorrhagic fever and dengue shock syndrome-is well defined. One of the results of the focus on dengue haemorrhagic fever is the false perception of low disease burden in the Americas, which is an obstacle to the mobilisation of political and economic resources to fight the disease. Three improvements are necessary to standardise the dengue haemorrhagic fever definition and to allow it to do well in different populations: (1) redefine the threshold for thrombocytopenia, (2) clarify the standard practice and value of the tourniquet test, and (3) incorporate a criterion to measure intravenous fluid replacement. In addition, for an accurate estimation of dengue burden, locally appropriate definitions of severe dengue must be devised and standardised so they will be considered valid in the global research community.

175 citations

Journal ArticleDOI
TL;DR: It is found that sRNA profiles are altered early in DENV2 infection, and mRNA targets from mitochondrial, transcription/translation, and transport functional categories are affected, indicating that specific cellular processes are affected during DENV infection, such as mitochondrial function and ncRNA levels.
Abstract: Background Small RNA (sRNA) regulatory pathways (SRRPs) are important to anti-viral defence in mosquitoes. To identify critical features of the virus infection process in Dengue serotype 2 (DENV2)-infected Ae. aegypti, we deep-sequenced small non-coding RNAs. Triplicate biological replicates were used so that rigorous statistical metrics could be applied.

175 citations

Journal ArticleDOI
TL;DR: An overview of Dengvaxia’s development is provided and what has been learned about product performance since its licensure is discussed.
Abstract: Dengue is the world's most prevalent and important arboviral disease. More than 50% of the world's population lives at daily risk of infection and it is estimated more than 95 million people a year seek medical care following infection. Severe disease can manifest as plasma leakage and potential for clinically significant hemorrhage, shock, and death. Treatment is supportive and there is currently no licensed anti-dengue virus prophylactic or therapeutic compound. A single dengue vaccine, Sanofi Pasteur's Dengvaxia®, has been licensed in 20 countries but uptake has been poor. A safety signal in dengue seronegative vaccine recipients stimulated an international re-look at the vaccine performance profile, new World Health Organization recommendations for use, and controversy in the Philippines involving the government, regulatory agencies, Sanofi Pasteur, clinicians responsible for testing and administering the vaccine, and the parents of vaccinated children. In this review, we provide an overview of Dengvaxia's® development and discuss what has been learned about product performance since its licensure.

175 citations

Journal ArticleDOI
TL;DR: Variation in spatial seroprevalence patterns inside the neighborhoods, with significantly higher risk patches close to the areas with large human movement, suggests that humans may be responsible for virus inflow to small neighborhoods in Rio de Janeiro.
Abstract: Background Rio de Janeiro, Brazil, experienced a severe dengue fever epidemic in 2008. This was the worst epidemic ever, characterized by a sharp increase in case-fatality rate, mainly among younger individuals. A combination of factors, such as climate, mosquito abundance, buildup of the susceptible population, or viral evolution, could explain the severity of this epidemic. The main objective of this study is to model the spatial patterns of dengue seroprevalence in three neighborhoods with different socioeconomic profiles in Rio de Janeiro. As blood sampling coincided with the peak of dengue transmission, we were also able to identify recent dengue infections and visually relate them to Aedes aegypti spatial distribution abundance. We analyzed individual and spatial factors associated with seroprevalence using Generalized Additive Model (GAM).

175 citations


Network Information
Related Topics (5)
Malaria
37K papers, 914K citations
88% related
Vaccination
65.1K papers, 1.7M citations
81% related
Virus
136.9K papers, 5.2M citations
80% related
Drug resistance
28.4K papers, 1.1M citations
80% related
Viral load
26.7K papers, 1M citations
79% related
Performance
Metrics
No. of papers in the topic in previous years
YearPapers
20241
20231,464
20222,917
2021992
20201,237
20191,168